| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYO9A MYO3A KIF2B KIF2A KIF5B KIF13B DNAH3 DNAH10 DNAH12 MYO16 | 3.71e-07 | 118 | 204 | 10 | GO:0003774 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO9A ATP8A2 ATP9B MYO3A KIF2B SMPDL3A KIF2A KIF5B HSP90AB1 KIF13B DNAH3 DNAH10 SLC27A6 HSPA4L ATP13A1 CHD9 CHD7 MORC2 NLRP10 DNAH12 | 5.26e-06 | 614 | 204 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | microtubule motor activity | 7.29e-06 | 70 | 204 | 7 | GO:0003777 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP8A2 ATP9B KIF2B SMPDL3A KIF2A KIF5B HSP90AB1 KIF13B DNAH3 DNAH10 ATP13A1 CHD9 CHD7 MORC2 NLRP10 DNAH12 | 1.29e-05 | 441 | 204 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | SERPINB13 SERPINB3 SERPINB4 C3 C5 AMBP NLRP2 SLCO1B7 APH1A SERPIND1 | 4.33e-05 | 201 | 204 | 10 | GO:0061135 |
| GeneOntologyMolecularFunction | enzyme regulator activity | MYO9A PDPK1 TBC1D2 MCF2L2 EPS8L1 WASH6P KAT2B SERPINB13 SERPINB3 SERPINB4 RAB3GAP2 C3 C5 GNAS SH3BP5 HSP90AB1 AMBP IPO7 WASHC1 PSD3 BCCIP PDPK2P MOB3A NLRP2 DENND1A SLCO1B7 ARHGAP1 APH1A DEF6 FGD6 SERPIND1 | 4.76e-05 | 1418 | 204 | 31 | GO:0030234 |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 8.52e-05 | 102 | 204 | 7 | GO:0016410 | |
| GeneOntologyMolecularFunction | histone binding | PHF19 ZZEF1 TRIM24 SPIN1 MCM3AP USP3 RAG1 IPO7 HAT1 CHD7 MORC2 | 9.30e-05 | 265 | 204 | 11 | GO:0042393 |
| GeneOntologyMolecularFunction | acetyltransferase activity | 9.64e-05 | 104 | 204 | 7 | GO:0016407 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | SERPINB13 SERPINB3 SERPINB4 C3 C5 AMBP NLRP2 SLCO1B7 SERPIND1 | 1.01e-04 | 180 | 204 | 9 | GO:0004866 |
| GeneOntologyMolecularFunction | 3-phosphoinositide-dependent protein kinase activity | 1.04e-04 | 2 | 204 | 2 | GO:0004676 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | SERPINB13 SERPINB3 SERPINB4 C3 C5 AMBP NLRP2 SLCO1B7 SERPIND1 | 1.35e-04 | 187 | 204 | 9 | GO:0030414 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAB23 ATP8A2 ATP9B KIF2B SMPDL3A KIF2A KIF5B GNAS ATL2 HSP90AB1 KIF13B DNAH3 DNAH10 ATP13A1 ATL3 CHD9 CHD7 MORC2 NLRP10 DNAH12 | 1.40e-04 | 775 | 204 | 20 | GO:0017111 |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 1.47e-04 | 78 | 204 | 6 | GO:0008080 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.70e-04 | 51 | 204 | 5 | GO:0004402 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.79e-04 | 28 | 204 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 2.43e-04 | 55 | 204 | 5 | GO:0061733 | |
| GeneOntologyMolecularFunction | histone H3K9 acetyltransferase activity | 3.10e-04 | 3 | 204 | 2 | GO:0043992 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | SERPINB13 SERPINB3 SERPINB4 C3 C5 AMBP NLRP2 SLCO1B7 APH1A SERPIND1 | 3.25e-04 | 257 | 204 | 10 | GO:0061134 |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 3.67e-04 | 60 | 204 | 5 | GO:0034212 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RAB23 ATP8A2 ATP9B KIF2B SMPDL3A KIF2A KIF5B GNAS ATL2 HSP90AB1 KIF13B DNAH3 DNAH10 ATP13A1 ATL3 CHD9 CHD7 MORC2 NLRP10 DNAH12 | 3.94e-04 | 839 | 204 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RAB23 ATP8A2 ATP9B KIF2B SMPDL3A KIF2A KIF5B GNAS ATL2 HSP90AB1 KIF13B DNAH3 DNAH10 ATP13A1 ATL3 CHD9 CHD7 MORC2 NLRP10 DNAH12 | 4.00e-04 | 840 | 204 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RAB23 ATP8A2 ATP9B KIF2B SMPDL3A KIF2A KIF5B GNAS ATL2 HSP90AB1 KIF13B DNAH3 DNAH10 ATP13A1 ATL3 CHD9 CHD7 MORC2 NLRP10 DNAH12 | 4.00e-04 | 840 | 204 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 4.37e-04 | 15 | 204 | 3 | GO:0010484 | |
| GeneOntologyMolecularFunction | antioxidant activity | 4.82e-04 | 97 | 204 | 6 | GO:0016209 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 7.35e-04 | 105 | 204 | 6 | GO:0004867 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 7.66e-04 | 18 | 204 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein-specific endopeptidase activity | 1.02e-03 | 5 | 204 | 2 | GO:0070137 | |
| GeneOntologyMolecularFunction | SUMO-specific endopeptidase activity | 1.02e-03 | 5 | 204 | 2 | GO:0070139 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | KAT2B SERPINB13 PXDN SERPINB3 SERPINB4 C3 C5 SH3BP5 HSP90AB1 TRAPPC2 AMBP TRAPPC2B NLRP2 SLCO1B7 SERPIND1 | 1.25e-03 | 596 | 204 | 15 | GO:0140678 |
| GeneOntologyMolecularFunction | protein kinase activity | CDK16 HK1 PDPK1 RPS6KA2 TRIM24 MYO3A TLK1 CPNE3 MAP2K4 NPR1 SGK1 PDPK2P CHEK2 PRKACG CDK3 | 1.33e-03 | 600 | 204 | 15 | GO:0004672 |
| GeneOntologyMolecularFunction | histone H4 acetyltransferase activity | 1.60e-03 | 23 | 204 | 3 | GO:0010485 | |
| GeneOntologyMolecularFunction | alpha-tubulin binding | 1.95e-03 | 52 | 204 | 4 | GO:0043014 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | CDK16 PDPK1 RPS6KA2 MYO3A TLK1 CPNE3 MAP2K4 SGK1 PDPK2P CHEK2 PRKACG CDK3 | 2.20e-03 | 446 | 204 | 12 | GO:0004674 |
| GeneOntologyMolecularFunction | metalloaminopeptidase activity | 2.30e-03 | 26 | 204 | 3 | GO:0070006 | |
| GeneOntologyMolecularFunction | acyltransferase activity | CHAT KAT2A ZZEF1 TRIM24 KAT2B MCM3AP ARIH2 CUL2 RAG1 ITCH NAA15 UBR4 RNF135 HAT1 NAA50 CERS5 UBE3C | 2.60e-03 | 775 | 204 | 17 | GO:0016746 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 2.65e-03 | 231 | 204 | 8 | GO:0005085 | |
| GeneOntologyMolecularFunction | sphingomyelin phosphodiesterase activity | 2.79e-03 | 8 | 204 | 2 | GO:0004767 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase inhibitor activity | 2.79e-03 | 8 | 204 | 2 | GO:0141039 | |
| GeneOntologyBiologicalProcess | intracellular transport | RAB23 FAM91A1 HNF4A CCDC38 WASH6P YIF1A TLK1 AP2S1 MIA2 RAB3GAP2 MCM3AP CLTC KIF2A KIF5B GNAS ATL2 DOP1B HSP90AB1 TRAPPC2 KPNA3 KPNA4 KIF13B WASHC4 IPO7 WASHC1 FERMT1 ATL3 SPG11 RILPL1 TRAPPC8 TRAPPC2B DENND1A ARHGAP1 PPP3CA DOP1A | 1.59e-06 | 1496 | 204 | 35 | GO:0046907 |
| GeneOntologyBiologicalProcess | cognition | CHAT KAT2A ZZEF1 BDNF KAT2B NLGN4X PTPRZ1 CYP7B1 GNAS DOP1B RAG1 WASHC4 NLGN4Y SGK1 SPG11 CHD7 | 5.16e-06 | 423 | 204 | 16 | GO:0050890 |
| GeneOntologyCellularComponent | intracellular protein-containing complex | KBTBD8 KAT2A WASH6P KAT2B ARIH2 ZER1 KIF2A HSP90AB1 TRAPPC2 CUL2 RAG1 ITCH NAA15 WASHC4 POLA1 WASHC1 NAA50 TRAPPC8 TRAPPC2B PPP3CA PRKACG UBE3C QRSL1 | 8.74e-05 | 972 | 205 | 23 | GO:0140535 |
| GeneOntologyCellularComponent | axonemal dynein complex | 9.67e-05 | 25 | 205 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.06e-04 | 10 | 205 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | DRC1 CCDC38 KIF2A IQUB DNAH3 DNAH10 DNAH12 CCDC42 MROH2B DRC3 | 1.26e-04 | 238 | 205 | 10 | GO:0097729 |
| GeneOntologyCellularComponent | nuclear envelope | CMTM3 RB1CC1 SPIN1 MCM3AP OTULINL TRAPPC2 KPNA3 KPNA4 AMBP IPO7 POLA1 SMPD4 TRAPPC2B MTMR6 NLRP10 DPY19L4 | 1.37e-04 | 560 | 205 | 16 | GO:0005635 |
| GeneOntologyCellularComponent | TRAPPIII protein complex | 1.92e-04 | 12 | 205 | 3 | GO:1990072 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.95e-04 | 161 | 205 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | WASH complex | 3.88e-04 | 15 | 205 | 3 | GO:0071203 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 5.67e-04 | 4 | 205 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | TRAPP complex | 5.71e-04 | 17 | 205 | 3 | GO:0030008 | |
| GeneOntologyCellularComponent | sarcolemma | 5.91e-04 | 190 | 205 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | BLOC-1 complex | 6.80e-04 | 18 | 205 | 3 | GO:0031083 | |
| GeneOntologyCellularComponent | nuclear membrane | CMTM3 RB1CC1 SPIN1 MCM3AP TRAPPC2 KPNA4 AMBP SMPD4 TRAPPC2B NLRP10 DPY19L4 | 6.93e-04 | 349 | 205 | 11 | GO:0031965 |
| GeneOntologyCellularComponent | vesicle tethering complex | 7.09e-04 | 72 | 205 | 5 | GO:0099023 | |
| GeneOntologyCellularComponent | endoplasmic reticulum tubular network membrane | 9.39e-04 | 5 | 205 | 2 | GO:0098826 | |
| GeneOntologyCellularComponent | NatA complex | 9.39e-04 | 5 | 205 | 2 | GO:0031415 | |
| GeneOntologyCellularComponent | axonal growth cone | 9.77e-04 | 45 | 205 | 4 | GO:0044295 | |
| GeneOntologyCellularComponent | ruffle | 1.00e-03 | 206 | 205 | 8 | GO:0001726 | |
| GeneOntologyCellularComponent | kinesin complex | 1.35e-03 | 49 | 205 | 4 | GO:0005871 | |
| GeneOntologyCellularComponent | BLOC complex | 1.42e-03 | 23 | 205 | 3 | GO:0031082 | |
| GeneOntologyCellularComponent | centrosome | RAB23 KAT2A CCDC38 WASH6P KAT2B EFHC1 KIF2B KIF2A KIF5B TAF1D FLII RAPSN UBR4 WASHC1 BCCIP RILPL1 CCDC42 | 1.59e-03 | 770 | 205 | 17 | GO:0005813 |
| GeneOntologyCellularComponent | dynein complex | 1.94e-03 | 54 | 205 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 2.01e-03 | 230 | 205 | 8 | GO:0098562 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | GAD1 GALNT3 ATP9B CCDC38 BDNF RYR3 KIF5B GNAS HSP90AB1 TRAPPC2 SGK1 TRAPPC2B CCIN CYFIP2 ARHGAP1 MTMR6 CCDC42 DEF6 MYO16 | 2.18e-03 | 934 | 205 | 19 | GO:0048471 |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 2.38e-03 | 185 | 205 | 7 | GO:0009898 | |
| GeneOntologyCellularComponent | spindle | RPS6KA2 KBTBD8 KAT2A KAT2B EFHC1 KIF2B SPIN1 CLTC KIF2A TAF1D RB1 BCCIP | 2.46e-03 | 471 | 205 | 12 | GO:0005819 |
| Domain | Hist_acetylase_PCAF | 1.16e-04 | 2 | 202 | 2 | IPR016376 | |
| Domain | Dopey_N | 1.16e-04 | 2 | 202 | 2 | PF04118 | |
| Domain | PCAF_N | 1.16e-04 | 2 | 202 | 2 | IPR009464 | |
| Domain | NLGN4 | 1.16e-04 | 2 | 202 | 2 | IPR030025 | |
| Domain | Dopey_N | 1.16e-04 | 2 | 202 | 2 | IPR007249 | |
| Domain | PCAF_N | 1.16e-04 | 2 | 202 | 2 | PF06466 | |
| Domain | Peptidase_M1 | 2.55e-04 | 12 | 202 | 3 | IPR001930 | |
| Domain | Peptidase_M1_N | 3.29e-04 | 13 | 202 | 3 | IPR014782 | |
| Domain | Peptidase_M1 | 3.29e-04 | 13 | 202 | 3 | PF01433 | |
| Domain | ARM-type_fold | USP9Y RYR3 CLTC ZER1 KPNA3 KPNA4 IPO7 RNPEPL1 UBR4 NOM1 MROH2B LTA4H | 3.35e-04 | 339 | 202 | 12 | IPR016024 |
| Domain | RB_A | 3.47e-04 | 3 | 202 | 2 | IPR002720 | |
| Domain | DUF3452 | 3.47e-04 | 3 | 202 | 2 | PF11934 | |
| Domain | RB_B | 3.47e-04 | 3 | 202 | 2 | IPR002719 | |
| Domain | RB_C | 3.47e-04 | 3 | 202 | 2 | IPR015030 | |
| Domain | DUF3528 | 3.47e-04 | 3 | 202 | 2 | IPR021918 | |
| Domain | RB_fam | 3.47e-04 | 3 | 202 | 2 | IPR028309 | |
| Domain | RB_N | 3.47e-04 | 3 | 202 | 2 | IPR024599 | |
| Domain | RB_A | 3.47e-04 | 3 | 202 | 2 | PF01858 | |
| Domain | RB_B | 3.47e-04 | 3 | 202 | 2 | PF01857 | |
| Domain | DUF3528 | 3.47e-04 | 3 | 202 | 2 | PF12045 | |
| Domain | DUF3452 | 3.47e-04 | 3 | 202 | 2 | SM01367 | |
| Domain | Rb_C | 3.47e-04 | 3 | 202 | 2 | SM01369 | |
| Domain | RB_A | 3.47e-04 | 3 | 202 | 2 | SM01368 | |
| Domain | Serpin_CS | 3.77e-04 | 32 | 202 | 4 | IPR023795 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.16e-04 | 14 | 202 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 4.16e-04 | 14 | 202 | 3 | IPR013602 | |
| Domain | DHC_N2 | 4.16e-04 | 14 | 202 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.16e-04 | 14 | 202 | 3 | IPR011704 | |
| Domain | AAA_8 | 4.16e-04 | 14 | 202 | 3 | PF12780 | |
| Domain | AAA_5 | 4.16e-04 | 14 | 202 | 3 | PF07728 | |
| Domain | DHC_fam | 5.15e-04 | 15 | 202 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 5.15e-04 | 15 | 202 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 5.15e-04 | 15 | 202 | 3 | IPR004273 | |
| Domain | IQ | 5.19e-04 | 93 | 202 | 6 | PS50096 | |
| Domain | Serpin_dom | 5.97e-04 | 36 | 202 | 4 | IPR023796 | |
| Domain | SERPIN | 6.63e-04 | 37 | 202 | 4 | PS00284 | |
| Domain | SERPIN | 6.63e-04 | 37 | 202 | 4 | SM00093 | |
| Domain | Peptidase_M1_C | 6.88e-04 | 4 | 202 | 2 | IPR015211 | |
| Domain | DUF4200 | 6.88e-04 | 4 | 202 | 2 | IPR025252 | |
| Domain | Leuk-A4-hydro_C | 6.88e-04 | 4 | 202 | 2 | SM01263 | |
| Domain | DUF4200 | 6.88e-04 | 4 | 202 | 2 | PF13863 | |
| Domain | Leuk-A4-hydro_C | 6.88e-04 | 4 | 202 | 2 | PF09127 | |
| Domain | - | 6.88e-04 | 4 | 202 | 2 | 1.20.91.20 | |
| Domain | Serpin | 7.35e-04 | 38 | 202 | 4 | PF00079 | |
| Domain | Serpin_fam | 8.12e-04 | 39 | 202 | 4 | IPR000215 | |
| Domain | - | 8.95e-04 | 40 | 202 | 4 | 3.40.630.30 | |
| Domain | P-loop_NTPase | RAB23 MYO9A MYO3A KIF2B KIF2A KIF5B GNAS ATL2 KIF13B DNAH3 DNAH10 ATL3 CHD9 CHD7 TEP1 NLRP2 NLRP10 DNAH12 UTP25 MYO16 | 9.08e-04 | 848 | 202 | 20 | IPR027417 |
| Domain | Kinesin_motor_CS | 9.83e-04 | 41 | 202 | 4 | IPR019821 | |
| Domain | Anaphylatoxin_comp_syst | 1.14e-03 | 5 | 202 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.14e-03 | 5 | 202 | 2 | IPR001840 | |
| Domain | Nlgn | 1.14e-03 | 5 | 202 | 2 | IPR000460 | |
| Domain | Kinesin-like_fam | 1.18e-03 | 43 | 202 | 4 | IPR027640 | |
| Domain | - | 1.29e-03 | 44 | 202 | 4 | 3.40.850.10 | |
| Domain | Kinesin | 1.29e-03 | 44 | 202 | 4 | PF00225 | |
| Domain | KISc | 1.29e-03 | 44 | 202 | 4 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 1.29e-03 | 44 | 202 | 4 | PS00411 | |
| Domain | Kinesin_motor_dom | 1.29e-03 | 44 | 202 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 1.29e-03 | 44 | 202 | 4 | PS50067 | |
| Domain | Acyl_CoA_acyltransferase | 1.40e-03 | 45 | 202 | 4 | IPR016181 | |
| Domain | BRK | 1.70e-03 | 6 | 202 | 2 | SM00592 | |
| Domain | BRK_domain | 1.70e-03 | 6 | 202 | 2 | IPR006576 | |
| Domain | BRK | 1.70e-03 | 6 | 202 | 2 | PF07533 | |
| Domain | IQ | 1.85e-03 | 81 | 202 | 5 | SM00015 | |
| Domain | NACHT | 1.88e-03 | 23 | 202 | 3 | PS50837 | |
| Domain | NACHT_NTPase | 1.88e-03 | 23 | 202 | 3 | IPR007111 | |
| Domain | Acetyltransf_1 | 1.88e-03 | 23 | 202 | 3 | PF00583 | |
| Domain | ANATO | 2.36e-03 | 7 | 202 | 2 | SM00104 | |
| Domain | Arm_3 | 2.36e-03 | 7 | 202 | 2 | PF16186 | |
| Domain | Importing_su_alpha | 2.36e-03 | 7 | 202 | 2 | IPR024931 | |
| Domain | IBB | 2.36e-03 | 7 | 202 | 2 | PF01749 | |
| Domain | ANAPHYLATOXIN_2 | 2.36e-03 | 7 | 202 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 2.36e-03 | 7 | 202 | 2 | PS01177 | |
| Domain | Peptidase_C48_C | 2.36e-03 | 7 | 202 | 2 | IPR003653 | |
| Domain | Peptidase_C48 | 2.36e-03 | 7 | 202 | 2 | PF02902 | |
| Domain | ANATO | 2.36e-03 | 7 | 202 | 2 | PF01821 | |
| Domain | Arm_3 | 2.36e-03 | 7 | 202 | 2 | IPR032413 | |
| Domain | ULP_PROTEASE | 2.36e-03 | 7 | 202 | 2 | PS50600 | |
| Domain | Anaphylatoxin/fibulin | 2.36e-03 | 7 | 202 | 2 | IPR000020 | |
| Domain | GNAT_dom | 2.41e-03 | 25 | 202 | 3 | IPR000182 | |
| Domain | GNAT | 2.41e-03 | 25 | 202 | 3 | PS51186 | |
| Domain | Bromodomain_CS | 2.70e-03 | 26 | 202 | 3 | IPR018359 | |
| Domain | IQ_motif_EF-hand-BS | 2.94e-03 | 90 | 202 | 5 | IPR000048 | |
| Domain | IBB | 3.12e-03 | 8 | 202 | 2 | PS51214 | |
| Domain | A2M_N_2 | 3.12e-03 | 8 | 202 | 2 | SM01359 | |
| Domain | - | 3.12e-03 | 8 | 202 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 3.12e-03 | 8 | 202 | 2 | SM01361 | |
| Domain | A2M | 3.12e-03 | 8 | 202 | 2 | SM01360 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | E2F7 RB1CC1 ZBTB24 HOXA11 HOXD11 SERPINB3 SPIN1 CLTC ALB HSP90AB1 KPNA3 KPNA4 FLII RB1 HSPA4L PRDX4 CHD7 MORC2 NOM1 CHEK2 EIF3C | 6.47e-11 | 583 | 208 | 21 | 29844126 |
| Pubmed | INPP5A E2F7 KAT2A SSR3 TLK1 AP2S1 KIF2B SERPINB3 SERPINB4 RAB3GAP2 MCM3AP ARIH2 CLTC ECEL1 ATL2 USP3 KPNA3 KPNA4 ATP13A1 RBL2 POLA1 UBR4 SPG11 COLEC10 MORC2 ASH2L TMEM121 ARHGAP1 SMG8 CHEK2 | 4.29e-10 | 1327 | 208 | 30 | 32694731 | |
| Pubmed | ZER1 Contributes to the Carcinogenic Activity of High-Risk HPV E7 Proteins. | 1.24e-09 | 4 | 208 | 4 | 36346242 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | EMC1 HK1 URB2 SSR3 TRIM24 HPRT1 RAB3GAP2 ARIH2 CLTC CPNE3 TIMELESS KIF5B KPNA4 KIF13B FLII WASHC4 POLA1 UBR4 HAT1 MORC2 EIF3C | 1.93e-09 | 704 | 208 | 21 | 29955894 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HK1 MYO9A URB2 AP2S1 SERPINB3 SERPINB4 MCM3AP CLTC CPNE3 KIF2A KIF5B USP3 PARP12 HSP90AB1 KPNA3 FLII ITCH NAA15 WASHC4 IPO7 RB1 POLA1 UBR4 FERMT1 ATL3 CHD7 NAA50 SMG8 AHNAK2 | 2.88e-09 | 1353 | 208 | 29 | 29467282 |
| Pubmed | 2.09e-08 | 15 | 208 | 5 | 27644329 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EMC1 HK1 URB2 CCDC38 SERPINB3 HPRT1 RAB3GAP2 CLTC KIF2A KIF5B GNAS ATL2 PCYOX1 HSP90AB1 FLII IPO7 DNAH10 HSPA4L ATP13A1 POLA1 PRDX4 UBR4 BCCIP HAT1 CYFIP2 ERLIN2 EIF3C UBE3C | 3.53e-08 | 1425 | 208 | 28 | 30948266 |
| Pubmed | ANKRD30B FAM91A1 AP2S1 SPIN1 HPRT1 ARIH2 CLTC CPNE3 KIF2A GNAS HSP90AB1 KPNA3 KPNA4 CUL2 FLII WASHC4 IPO7 HSPA4L PRDX4 WASHC1 BCCIP HAT1 SPG11 ASH2L PPP3CA NOM1 EIF3C | 3.53e-08 | 1335 | 208 | 27 | 29229926 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HK1 TBC1D2 ZZEF1 HPRT1 RAB3GAP2 ARIH2 TIMELESS KIF5B HSP90AB1 KPNA3 KPNA4 CUL2 FLII NAA15 WASHC4 IPO7 HSPA4L POLA1 PRDX4 UBR4 BCCIP HAT1 IDH1 PPP3CA FTH1 EIF3C UBE3C AHNAK2 | 5.44e-08 | 1455 | 208 | 28 | 22863883 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | HK1 NLN SERPINB13 SERPINB3 CLTC KIF5B GNAS ATL2 APOL2 PCYOX1 HSP90AB1 CUL2 ITCH NAA15 PRDX4 UBR4 ATL3 BCCIP HAT1 SMPD4 IDH1 NAA50 ARHGAP1 PTGR1 LTA4H EIF3C AHNAK2 | 5.71e-08 | 1367 | 208 | 27 | 32687490 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | EMC1 URB2 SSR3 YIF1A PXDN RAB3GAP2 CLTC GPC4 TIMELESS KIF5B OTULINL HSP90AB1 ITCH NAA15 IPO7 HSPA4L ATP13A1 UBR4 HAT1 CERS5 ERLIN2 APH1A | 6.26e-08 | 942 | 208 | 22 | 31073040 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | EMC1 E2F7 SSR3 RB1CC1 HNF4A ZBTB24 TLK1 AP2S1 SERPINB3 SERPINB4 HPRT1 RAB3GAP2 CLTC KIF5B GNAS KPNA3 KPNA4 CUL2 HSPA4L SGK1 UBR4 BCCIP SMPD4 ARR3 NOM1 LTA4H | 6.33e-08 | 1284 | 208 | 26 | 17353931 |
| Pubmed | NR2C1 MCF2L2 USP9Y MTMR10 RYR3 MIA2 ARIH2 CLTC SH3BP5 DOP1B HSP90AB1 KPNA3 KPNA4 FLII ITCH WASHC4 ATP13A1 RBL2 UBR4 CHD9 RILPL1 ARHGAP1 PPP3CA ASPA SENP6 EIF3C | 6.43e-08 | 1285 | 208 | 26 | 35914814 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | CDK16 E2F7 TRIM24 SPIN1 GPC4 ALB KPNA3 KPNA4 FLII IPO7 RB1 HSPA4L RBL2 CHD7 | 1.47e-07 | 398 | 208 | 14 | 35016035 |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 1.65e-07 | 182 | 208 | 10 | 30711629 | |
| Pubmed | 2.11e-07 | 3 | 208 | 3 | 27461873 | ||
| Pubmed | Alterations in gene expression of complement components in chronic rhinosinusitis. | 2.11e-07 | 3 | 208 | 3 | 20109314 | |
| Pubmed | 2.25e-07 | 23 | 208 | 5 | 39226900 | ||
| Pubmed | EMC1 URB2 RB1CC1 PXDN HPRT1 CLTC C3 ECEL1 GNAS PCYOX1 HSP90AB1 KPNA3 KPNA4 CUL2 ITCH IPO7 UBR4 BCCIP ARHGAP1 MTMR6 ERLIN2 PPP3CA FTH1 CHEK2 UBE3C | 2.91e-07 | 1297 | 208 | 25 | 33545068 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | EMC1 HK1 AP2S1 HPRT1 CLTC KIF5B GNAS HSP90AB1 KPNA3 CUL2 FLII SLC25A21 IPO7 HSPA4L PRDX4 UBR4 BCCIP HAT1 SMPD4 ERLIN2 PPP3CA NOM1 EIF3C UBE3C | 6.06e-07 | 1257 | 208 | 24 | 37317656 |
| Pubmed | KBTBD8 FAM91A1 SSR3 AP2S1 SPIN1 MCM3AP CLTC KIF5B C5 GNAS PARP12 TAF1D HSP90AB1 KPNA3 AMBP FLII IPO7 ATP13A1 PRDX4 BCCIP CHD7 MORC2 DENND1A NOM1 FTH1 | 8.03e-07 | 1371 | 208 | 25 | 36244648 | |
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 31076642 | ||
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 23727383 | ||
| Pubmed | The role of MAP2 kinases and p38 kinase in acute murine liver injury models. | 8.40e-07 | 4 | 208 | 3 | 28661486 | |
| Pubmed | Complement C3b interactions studied with surface plasmon resonance technique. | 8.40e-07 | 4 | 208 | 3 | 11367533 | |
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 20033053 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | NR2C1 TRIM24 ZBTB24 SPIN1 TIMELESS USP3 IPO7 RB1 POLA1 BCCIP HAT1 CHD9 CHD7 MORC2 SENP6 SENP7 | 9.23e-07 | 608 | 208 | 16 | 36089195 |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 9.92e-07 | 171 | 208 | 9 | 20201926 | |
| Pubmed | CDK16 HK1 PHF19 AP2S1 HPRT1 CLTC KPNA3 KPNA4 CUL2 RB1 HSPA4L UBR4 IDH1 NOM1 CHEK2 UBE3C | 1.59e-06 | 634 | 208 | 16 | 34591612 | |
| Pubmed | HK1 ANKRD30B KAT2A SSR3 DCC TLK1 PXDN MIA2 CLTC GPC4 SCN9A KIF5B METTL25 HSP90AB1 TRAPPC2 KPNA4 KIF13B MACC1 HSPA4L PRDX4 UBR4 SPG11 CYFIP2 ERLIN2 DOP1A | 1.98e-06 | 1442 | 208 | 25 | 35575683 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | USP9Y RYR3 KIF2B HOXD11 SCN9A KIF2A KPNA4 FLII HSPA4L CHD9 SPG11 MORC2 ERLIN2 DNAH12 | 2.06e-06 | 497 | 208 | 14 | 36774506 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | EPS8L1 CFB PXDN SMPDL3A CLTC CPNE3 C3 ALB C5 GNAS DOP1B HSP90AB1 AMBP ITCH GPX3 IDH1 CYFIP2 ARHGAP1 FTH1 LTA4H SERPIND1 | 2.09e-06 | 1070 | 208 | 21 | 23533145 |
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 25624444 | ||
| Pubmed | Characterization of the murine orthologue of a novel human subtelomeric multigene family. | 2.09e-06 | 5 | 208 | 3 | 11701968 | |
| Pubmed | EMC1 FAM91A1 SSR3 ZZEF1 WASH6P CPNE3 TIMELESS KIF2A PARP12 CUL2 NAA15 ATL3 MORC2 ASH2L SMG8 NOM1 | 2.19e-06 | 650 | 208 | 16 | 38777146 | |
| Pubmed | HK1 PDPK1 RB1CC1 RAB3GAP2 CLTC GPC4 KIF5B CUL2 NAA15 ATG2B HAT1 TRAPPC8 LTA4H | 2.66e-06 | 437 | 208 | 13 | 20562859 | |
| Pubmed | HK1 RAB3GAP2 CLTC ALB KIF5B APOL2 HSP90AB1 NAA15 IDH1 ERLIN2 AHNAK2 | 3.20e-06 | 312 | 208 | 11 | 37120454 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | EPS8L1 HSPA12A SERPINB13 SERPINB3 CLTC CPNE3 ALB C5 PCYOX1 DOP1B AMBP TUT4 RBL2 IDH1 NAA50 CYFIP2 ARHGAP1 PTGR1 FTH1 LTA4H | 3.54e-06 | 1016 | 208 | 20 | 19056867 |
| Pubmed | Human subtelomeric WASH genes encode a new subclass of the WASP family. | 4.16e-06 | 6 | 208 | 3 | 18159949 | |
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 25888260 | ||
| Pubmed | The Complement System Is Critical in Maintaining Retinal Integrity during Aging. | 4.16e-06 | 6 | 208 | 3 | 29497373 | |
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 19843088 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK16 EMC1 MYO9A RPS6KA2 RAB3GAP2 KIF2A KIF5B GNAS DOP1B KIF13B ITCH NAA15 PSD3 DENND1A FGD6 DOP1A CDK3 AHNAK2 | 4.92e-06 | 861 | 208 | 18 | 36931259 |
| Pubmed | GAD1 EMC1 FAM91A1 HSPA12A AP2S1 HPRT1 RAB3GAP2 CLTC KIF2A KIF5B HSP90AB1 FLII MAP2K4 TUT4 NAA15 ATP13A1 UBR4 ATG2B PSD3 ERLIN2 EIF3C | 5.47e-06 | 1139 | 208 | 21 | 36417873 | |
| Pubmed | Next-generation sequencing to generate interactome datasets. | RAB23 GAD1 TMEM128 STAC3 BMP7 MIA2 ARIH2 GPC4 KIF2A KPNA3 IDH1 MOB3A TRAPPC2B ASH2L ARHGAP1 MTMR6 ARR3 PPP3CA APH1A FTH1 UBE3C | 6.09e-06 | 1147 | 208 | 21 | 21516116 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HK1 SPIN1 HPRT1 RAB3GAP2 CLTC KIF5B GNAS HSP90AB1 KPNA3 KPNA4 FLII NAA15 IPO7 HSPA4L PRDX4 UBR4 HAT1 IDH1 ASH2L CYFIP2 LTA4H | 6.25e-06 | 1149 | 208 | 21 | 35446349 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | CFB WASH6P SCN9A C3 ALB KPNA3 NAA15 HSPA4L UBR4 BTBD10 WASHC1 PSD3 MORC2 | 6.55e-06 | 475 | 208 | 13 | 31040226 |
| Pubmed | 6.87e-06 | 21 | 208 | 4 | 37422473 | ||
| Pubmed | Efficient osteoclast differentiation requires local complement activation. | 7.25e-06 | 7 | 208 | 3 | 20709903 | |
| Pubmed | Mesomelic dysplasias associated with the HOXD locus are caused by regulatory reallocations. | 7.25e-06 | 7 | 208 | 3 | 34408147 | |
| Pubmed | Functional organization of the yeast proteome by systematic analysis of protein complexes. | 7.25e-06 | 7 | 208 | 3 | 11805826 | |
| Pubmed | HK1 SSR3 CLTC GPC4 ALB KIF5B GNAS APOL2 HSP90AB1 DNAH3 NAA15 PRDX4 HAT1 IDH1 PPP3CA NOM1 EIF3C | 7.72e-06 | 803 | 208 | 17 | 36517590 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 8.11e-06 | 221 | 208 | 9 | 29991511 | |
| Pubmed | HK1 ATP8A2 RPS6KA2 KAT2A TLK1 KAT2B ARIH2 CPNE3 ECEL1 CUL2 TUT4 DNAH10 SGK1 MTMR6 EIF3C CDK3 | 9.41e-06 | 730 | 208 | 16 | 34857952 | |
| Pubmed | EMC1 HK1 RB1CC1 TRIM24 HSPA12A ERAP2 RAB3GAP2 CLTC GNAS CUL2 ITCH NAA15 IPO7 HSPA4L ATP13A1 PRDX4 UBR4 PSD3 BCCIP SMPD4 SPG11 TRAPPC8 ARHGAP1 QRSL1 | 1.07e-05 | 1487 | 208 | 24 | 33957083 | |
| Pubmed | 1.15e-05 | 8 | 208 | 3 | 29055016 | ||
| Pubmed | A FAM21-containing WASH complex regulates retromer-dependent sorting. | 1.15e-05 | 8 | 208 | 3 | 19922874 | |
| Pubmed | 1.15e-05 | 8 | 208 | 3 | 24474777 | ||
| Pubmed | Differentially regulated and evolved genes in the fully sequenced Xq/Yq pseudoautosomal region. | 1.15e-05 | 8 | 208 | 3 | 10655549 | |
| Pubmed | Molecular organization and function of the complement system. | 1.15e-05 | 8 | 208 | 3 | 3052276 | |
| Pubmed | 1.15e-05 | 8 | 208 | 3 | 28301559 | ||
| Pubmed | Organ size control is dominant over Rb family inactivation to restrict proliferation in vivo. | 1.15e-05 | 8 | 208 | 3 | 25017070 | |
| Pubmed | The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway. | 1.15e-05 | 8 | 208 | 3 | 23453634 | |
| Pubmed | The role of complement in cryoglobulin-induced immune complex glomerulonephritis. | 1.15e-05 | 8 | 208 | 3 | 16272350 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.33e-05 | 179 | 208 | 8 | 36261009 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | EMC1 URB2 YIF1A PCYOX1 KPNA3 KPNA4 CUL2 FLII SLC25A21 WASHC4 IPO7 ATP13A1 POLA1 ATL3 EIF3C UBE3C | 1.40e-05 | 754 | 208 | 16 | 33060197 |
| Pubmed | EMC1 MIA2 RAB3GAP2 OTULINL ATL2 HSPA4L ATL3 SMPD4 ARHGAP1 ERLIN2 | 1.43e-05 | 299 | 208 | 10 | 37931956 | |
| Pubmed | 1.72e-05 | 9 | 208 | 3 | 21775285 | ||
| Pubmed | Chromatin "prepattern" and histone modifiers in a fate choice for liver and pancreas. | 1.72e-05 | 9 | 208 | 3 | 21596989 | |
| Pubmed | RAB23 SSR3 YIF1A CLTC CPNE3 GNAS ATL2 APOL2 HSP90AB1 ATP13A1 PRDX4 ATL3 SMPD4 NAA50 TRAPPC8 ARHGAP1 ERLIN2 DEF6 | 1.90e-05 | 952 | 208 | 18 | 38569033 | |
| Pubmed | EMC1 FAM91A1 RB1CC1 MTMR10 HSPA12A PTPRZ1 CLTC HSP90AB1 KPNA3 KPNA4 IPO7 PSD3 SMPD4 NAA50 CYFIP2 ARHGAP1 MTMR6 PPP3CA EIF3C | 2.00e-05 | 1049 | 208 | 19 | 27880917 | |
| Pubmed | Evidence that the transcriptional repressor ICER is regulated via the N-end rule for ubiquitination. | 2.27e-05 | 28 | 208 | 4 | 35227662 | |
| Pubmed | A Non-canonical PDK1-RSK Signal Diminishes Pro-caspase-8-Mediated Necroptosis Blockade. | 2.45e-05 | 10 | 208 | 3 | 32979304 | |
| Pubmed | MYO9A TRIM24 RAB3GAP2 KIF5B GNAS WASHC4 UBR4 ARHGAP1 MTMR6 PPP3CA | 2.69e-05 | 322 | 208 | 10 | 26514267 | |
| Pubmed | E2F7 RB1CC1 SPIN1 HPRT1 CLTC KIF2A ALB KIF5B HSP90AB1 HSPA4L PRDX4 UBR4 EIF3C | 3.11e-05 | 551 | 208 | 13 | 34728620 | |
| Pubmed | KBTBD8 FAM91A1 ZBTB24 SPIN1 CLTC CPNE3 GPC4 P2RY14 TIMELESS KIF2A OTULINL USP3 PARP12 KPNA3 KIF13B MAP2K4 CHD7 ASH2L MTMR6 | 3.12e-05 | 1084 | 208 | 19 | 11544199 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | HK1 ZZEF1 HPRT1 CLTC CPNE3 GNAS HSP90AB1 PRDX4 UBR4 IDH1 CYFIP2 ARHGAP1 ERLIN2 LTA4H MYO16 AHNAK2 | 3.18e-05 | 807 | 208 | 16 | 30575818 |
| Pubmed | 3.36e-05 | 11 | 208 | 3 | 15203215 | ||
| Pubmed | 3.36e-05 | 11 | 208 | 3 | 22509482 | ||
| Pubmed | TBC1D2 URB2 PXDN CLTC OTULINL APOL2 HSP90AB1 ARHGAP1 KCTD20 AHNAK2 | 3.48e-05 | 332 | 208 | 10 | 37433992 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | EMC1 HK1 ZZEF1 MIA2 RAB3GAP2 CLTC KIF2A GNAS APOL2 FLII TUT4 NAA15 HSPA4L UBR4 ATG2B SMPD4 NAA50 ARHGAP1 ERLIN2 NOM1 UBE3C QRSL1 AHNAK2 | 3.51e-05 | 1496 | 208 | 23 | 32877691 |
| Pubmed | Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure. | 3.56e-05 | 2 | 208 | 2 | 23354406 | |
| Pubmed | Epinephrine-induced hyperpolarization of pancreatic islet cells is sensitive to PI3K-PDK1 signaling. | 3.56e-05 | 2 | 208 | 2 | 19716369 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 21730187 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 23354437 | ||
| Pubmed | Reduced intestinal and renal amino acid transport in PDK1 hypomorphic mice. | 3.56e-05 | 2 | 208 | 2 | 17077298 | |
| Pubmed | C1q is elevated during chronic Staphylococcus epidermidis central nervous system catheter infection. | 3.56e-05 | 2 | 208 | 2 | 38881889 | |
| Pubmed | 3'Phosphoinositide-dependent kinase-1 is essential for ischemic preconditioning of the myocardium. | 3.56e-05 | 2 | 208 | 2 | 17077284 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 24281253 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 20837143 | ||
| Pubmed | Phosphoinositide-dependent kinase PDK1 in the regulation of Ca2+ entry into mast cells. | 3.56e-05 | 2 | 208 | 2 | 21063107 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 34331779 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 33377210 | ||
| Pubmed | Impairment of immunological memory in the absence of MHC despite survival of memory T cells. | 3.56e-05 | 2 | 208 | 2 | 11836529 | |
| Pubmed | Essential role of PDK1 in regulating endothelial cell migration. | 3.56e-05 | 2 | 208 | 2 | 17371830 | |
| Pubmed | Reduced Ca2+ entry and suicidal death of erythrocytes in PDK1 hypomorphic mice. | 3.56e-05 | 2 | 208 | 2 | 17899170 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 34270849 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 19088454 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 19088455 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 22234447 | ||
| Interaction | AGPAT1 interactions | RPS6KA2 EPS8L1 CFB SERPINB13 SERPINB3 SERPINB4 C3 ALB C5 OTULINL FERMT1 GPX3 SERPIND1 AHNAK2 | 7.96e-07 | 269 | 207 | 14 | int:AGPAT1 |
| Interaction | PHF11 interactions | CFB SERPINB13 SERPINB3 SERPINB4 C3 ALB C5 ARHGAP1 SERPIND1 AHNAK2 | 1.55e-06 | 137 | 207 | 10 | int:PHF11 |
| Interaction | CIC interactions | E2F7 RB1CC1 HNF4A ZBTB24 HOXA11 HOXD11 SERPINB3 SPIN1 CLTC ALB HSP90AB1 KPNA3 KPNA4 FLII RB1 HSPA4L PRDX4 CHD7 MORC2 NOM1 CHEK2 EIF3C | 1.80e-06 | 673 | 207 | 22 | int:CIC |
| Interaction | SSUH2 interactions | EPS8L1 CFB SERPINB13 SERPINB3 SERPINB4 C3 FERMT1 ATL3 NLRP2 ARHGAP1 AHNAK2 | 7.01e-06 | 199 | 207 | 11 | int:SSUH2 |
| Interaction | CRYL1 interactions | 2.31e-05 | 56 | 207 | 6 | int:CRYL1 | |
| Interaction | CCR1 interactions | EPS8L1 CFB SERPINB13 SERPINB3 SERPINB4 C3 ALB C5 PCYOX1 KIF13B GPX3 ATL3 ARHGAP1 NLRP10 | 2.34e-05 | 361 | 207 | 14 | int:CCR1 |
| Interaction | IFITM3 interactions | FAM91A1 WASH6P CLTC GNAS ATL2 CUL2 ITCH WASHC4 HSPA4L UBR4 ATL3 TRAPPC8 ARHGAP1 MTMR6 ERLIN2 UBE3C AHNAK2 | 2.38e-05 | 513 | 207 | 17 | int:IFITM3 |
| Interaction | RAB11A interactions | RAB23 CDK16 HK1 FAM91A1 KAT2B SERPINB3 SERPINB4 CLTC CPNE3 KIF5B SH3BP5 DOP1B KIF13B PSD3 SMPD4 RILPL1 TRAPPC8 NIPAL3 ARHGAP1 MTMR6 DOP1A AHNAK2 | 4.72e-05 | 830 | 207 | 22 | int:RAB11A |
| Cytoband | 18q21.3 | 1.47e-05 | 11 | 208 | 3 | 18q21.3 | |
| Cytoband | 18q23 | 3.07e-04 | 29 | 208 | 3 | 18q23 | |
| GeneFamily | Serpin peptidase inhibitors | 1.76e-04 | 37 | 138 | 4 | 739 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 2.27e-04 | 16 | 138 | 3 | 14 | |
| GeneFamily | Dyneins, axonemal | 2.74e-04 | 17 | 138 | 3 | 536 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.74e-04 | 17 | 138 | 3 | 486 | |
| GeneFamily | Armadillo repeat containing|Importins | 3.26e-04 | 18 | 138 | 3 | 596 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 4.13e-04 | 46 | 138 | 4 | 622 | |
| GeneFamily | GCN5 related N-acetyltransferases | 7.83e-04 | 24 | 138 | 3 | 1134 | |
| GeneFamily | WASH complex | 8.50e-04 | 6 | 138 | 2 | 1331 | |
| GeneFamily | SUMO specific peptidases | 1.18e-03 | 7 | 138 | 2 | 984 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.01e-03 | 9 | 138 | 2 | 1234 | |
| GeneFamily | Complement system|Sushi domain containing | 2.58e-03 | 36 | 138 | 3 | 492 | |
| GeneFamily | Dynein regulatory complex | 3.04e-03 | 11 | 138 | 2 | 981 | |
| GeneFamily | N(alpha)-acetyltransferase subunits|GCN5 related N-acetyltransferases | 3.63e-03 | 12 | 138 | 2 | 660 | |
| GeneFamily | ATAC complex | 4.27e-03 | 13 | 138 | 2 | 1058 | |
| GeneFamily | Trafficking protein particle complex | 4.96e-03 | 14 | 138 | 2 | 772 | |
| GeneFamily | ATPase phospholipid transporting | 5.69e-03 | 15 | 138 | 2 | 1210 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 5.69e-03 | 15 | 138 | 2 | 903 | |
| GeneFamily | Lysine acetyltransferases|ATAC complex|SAGA complex|GCN5 related N-acetyltransferases | 7.30e-03 | 17 | 138 | 2 | 1059 | |
| GeneFamily | Heat shock 70kDa proteins | 7.30e-03 | 17 | 138 | 2 | 583 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RPS6KA2 RB1CC1 ZZEF1 TRIM24 BDNF TLK1 MIA2 KIF2A DOP1B KPNA3 CUL2 MAP2K4 TUT4 ITCH WASHC4 IPO7 RB1 PSD3 HAT1 CHD9 SPG11 TRAPPC8 | 1.41e-06 | 856 | 208 | 22 | M4500 |
| Coexpression | HADDAD_B_LYMPHOCYTE_PROGENITOR | RB1CC1 KAT2B EFHC1 PXDN P2RY14 RAG1 WASHC4 RB1 PSD3 CHD7 CYFIP2 QRSL1 | 3.88e-06 | 290 | 208 | 12 | M939 |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE | GALNT3 KBTBD8 TBC1D2 FAM91A1 C11orf24 RB1CC1 MTMR10 YIF1A CSGALNACT2 SCN9A KIF5B USP3 KPNA3 FLII MACC1 SGK1 GPX3 MOB3A DENND1A ARHGAP1 MTMR6 FTH1 PRKACG EIF3C FGD6 AHNAK2 | 7.26e-06 | 1250 | 208 | 26 | M41099 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | GAD1 URB2 TRIM24 ZBTB24 NLN TXNL4A SPIN1 HPRT1 TIMELESS ATL2 PARP12 TAF1D MAP2K4 NAA15 POLA1 FERMT1 IDH1 RILPL1 NAA50 DENND1A UTP25 NOM1 DPY19L4 CHEK2 SENP6 UBE3C FGD6 | 2.02e-05 | 1407 | 208 | 27 | M14427 |
| Coexpression | IBRAHIM_NRF2_UP | FAM91A1 RB1CC1 NLN CSGALNACT2 KIF2A KIF5B HSP90AB1 KPNA4 CUL2 ITCH BTBD10 NAA50 SMG8 FTH1 KCTD20 | 2.56e-05 | 533 | 208 | 15 | M42510 |
| Coexpression | GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_UP | 3.21e-05 | 199 | 208 | 9 | M9220 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP | 3.34e-05 | 200 | 208 | 9 | M9922 | |
| Coexpression | GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN | 3.34e-05 | 200 | 208 | 9 | M7744 | |
| Coexpression | GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP | 3.34e-05 | 200 | 208 | 9 | M5623 | |
| Coexpression | SNF5_DN.V1_DN | 3.82e-05 | 157 | 208 | 8 | M2715 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | NR2C1 PHF19 TBC1D2 ANKRD30B KAT2A ZZEF1 CSGALNACT2 SMPDL3A MCM3AP OTULINL USP3 DOP1B FLII TUT4 ATP13A1 UBR4 WASHC1 MOB3A NLRP2 ARHGAP1 | 3.83e-05 | 905 | 208 | 20 | M40865 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | GALNT3 RPS6KA2 C11orf24 ATP9B RYR3 EFHC1 ERAP2 RAB3GAP2 SCN9A P2RY14 TIMELESS OTULINL WASHC4 IPO7 RBL2 PRDX4 CHD9 TRAPPC8 CYFIP2 ERLIN2 PPP3CA UTP25 KCTD20 SENP6 | 3.84e-05 | 1215 | 208 | 24 | M41122 |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | CDK16 GAD1 NR2C1 ATP8A2 RB1CC1 USP9Y TLK1 AP2S1 HPRT1 ARIH2 CLTC KIF2A GNAS HSP90AB1 KPNA3 CUL2 MAP2K4 IPO7 HSPA4L PRDX4 PSD3 ASH2L PPP3CA UTP25 | 5.84e-05 | 1248 | 208 | 24 | M17728 |
| Coexpression | GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_UP | 6.48e-05 | 125 | 208 | 7 | M473 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | NR2C1 PHF19 ATP9B SSR3 BDNF TXNL4A CSGALNACT2 ERAP2 SPIN1 KIF2A TAF1D KPNA3 NAA15 POLA1 ATL3 NAA50 PPP3CA DOP1A SENP7 | 7.83e-05 | 877 | 208 | 19 | M2241 |
| Coexpression | AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN | 1.23e-04 | 237 | 208 | 9 | M8897 | |
| Coexpression | HOELZEL_NF1_TARGETS_UP | 1.38e-04 | 141 | 208 | 7 | M2142 | |
| Coexpression | VANASSE_BCL2_TARGETS_UP | 1.48e-04 | 34 | 208 | 4 | M1906 | |
| Coexpression | DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER | 1.49e-04 | 100 | 208 | 6 | M14670 | |
| Coexpression | GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP | 1.86e-04 | 197 | 208 | 8 | M8022 | |
| Coexpression | GSE15330_WT_VS_IKAROS_KO_HSC_DN | 1.99e-04 | 199 | 208 | 8 | M7036 | |
| Coexpression | GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_UP | 1.99e-04 | 199 | 208 | 8 | M9596 | |
| Coexpression | GSE21379_WT_VS_SAP_KO_CD4_TCELL_DN | 1.99e-04 | 199 | 208 | 8 | M7511 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN | 1.99e-04 | 199 | 208 | 8 | M5257 | |
| Coexpression | GSE17721_0.5H_VS_8H_LPS_BMDC_DN | 1.99e-04 | 199 | 208 | 8 | M4075 | |
| Coexpression | GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN | 2.06e-04 | 200 | 208 | 8 | M8032 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 2.06e-04 | 200 | 208 | 8 | M9313 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN | 2.06e-04 | 200 | 208 | 8 | M4527 | |
| Coexpression | GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP | 2.06e-04 | 200 | 208 | 8 | M8625 | |
| Coexpression | GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_UP | 2.06e-04 | 200 | 208 | 8 | M8844 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_DN | 2.06e-04 | 200 | 208 | 8 | M3895 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP | 2.06e-04 | 200 | 208 | 8 | M6653 | |
| Coexpression | HALLMARK_XENOBIOTIC_METABOLISM | 2.06e-04 | 200 | 208 | 8 | M5934 | |
| Coexpression | GSE17721_0.5H_VS_8H_CPG_BMDC_UP | 2.06e-04 | 200 | 208 | 8 | M4126 | |
| Coexpression | GSE11924_TH2_VS_TH17_CD4_TCELL_DN | 2.06e-04 | 200 | 208 | 8 | M3165 | |
| Coexpression | DESCARTES_FETAL_STOMACH_MESOTHELIAL_CELLS | 2.07e-04 | 37 | 208 | 4 | M40310 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | MYO3A KAT2B SERPINB4 SPIN1 CLTC KIF5B GNAS OTULINL HSP90AB1 IPO7 HSPA4L PSD3 CHD9 CHD7 TRAPPC8 CYFIP2 MTMR6 FTH1 UBE3C | 2.07e-04 | 946 | 208 | 19 | M39169 |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING | CDK16 RPS6KA2 RB1CC1 KAT2B CSGALNACT2 ZER1 RB1 PSD3 SMAGP ERLIN2 PPP3CA DEF6 CDK3 | 2.18e-04 | 506 | 208 | 13 | M253 |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 | NR2C1 GALNT3 INPP5A PDPK1 TBC1D2 BDNF CFB KAT2B PTPRZ1 GPC4 C3 GNAS SLC51A IDH1 FTH1 FGD6 | 2.40e-04 | 726 | 208 | 16 | M4210 |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.12e-07 | 184 | 207 | 9 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.66e-07 | 189 | 207 | 9 | 533c302df467d13ab639232daf4f8cafb808260b | |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | BMP7 SERPINB13 PTPRZ1 SERPINB3 SERPINB4 HSPA4L NLGN4Y FERMT1 AHNAK2 | 2.90e-07 | 191 | 207 | 9 | a98915bad9a4a61dd4cbca798914849b805f4a19 |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | BNC1 BMP7 SERPINB13 PTPRZ1 SERPINB3 SERPINB4 HSPA4L FERMT1 AHNAK2 | 3.17e-07 | 193 | 207 | 9 | 7c34abdcb8839b9fb25457a79af6c5e7b9714b21 |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 3.93e-07 | 198 | 207 | 9 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.93e-07 | 198 | 207 | 9 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-MUC5AC+_High|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | EPS8L1 CFB SERPINB13 PTPRZ1 SERPINB3 SERPINB4 SLC51A SLC27A6 FERMT1 | 4.10e-07 | 199 | 207 | 9 | a5240868cea40574ed4ee45eb27a00c1812957ed |
| ToppCell | (05)_Secretory-(1)_GFP|(05)_Secretory / shred by cell type by condition | 4.39e-07 | 100 | 207 | 7 | 838340a2b7c76f603e0ef2fe4fd170bd0dbce685 | |
| ToppCell | TCGA-Cervix|World / Sample_Type by Project: Shred V9 | 1.36e-06 | 170 | 207 | 8 | a6cbe253bc60f5d5cb361c7e85ed9928a3155ec8 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | BNC1 SERPINB13 HOXD11 SERPINB3 SERPINB4 HSPA4L NLRP10 AHNAK2 | 1.42e-06 | 171 | 207 | 8 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Metaplastic_Carcinoma-4|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.78e-06 | 123 | 207 | 7 | 11802979943a9205f10facda322fc220d4bf7133 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Metaplastic_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.78e-06 | 123 | 207 | 7 | 51e49a64fbbf77e2ee21f45fd515d43282b11516 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-06 | 185 | 207 | 8 | e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.23e-06 | 191 | 207 | 8 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.49e-06 | 193 | 207 | 8 | 088c8b1e968f5356502347eaabdc6b1b1d4befd0 | |
| ToppCell | BL-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.63e-06 | 194 | 207 | 8 | 2932f704656ca368565ec12f3452af3b18e8df12 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | BMP7 SERPINB13 PTPRZ1 SERPINB3 SERPINB4 HSPA4L FERMT1 AHNAK2 | 4.06e-06 | 197 | 207 | 8 | fb272c9c60ee3d980e528044dc567b4925a23da6 |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.06e-06 | 197 | 207 | 8 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | BMP7 SERPINB13 PTPRZ1 SERPINB3 SERPINB4 HSPA4L FERMT1 AHNAK2 | 4.06e-06 | 197 | 207 | 8 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.06e-06 | 197 | 207 | 8 | 1638959d7aecb9fc5285eb7e4a3103ca437989e2 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-06 | 198 | 207 | 8 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 4.22e-06 | 198 | 207 | 8 | 6b6572deeca98ccb015f2aa3c5ce27de44445f74 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.22e-06 | 198 | 207 | 8 | c4e7512f0e1d115f2be8acae6048eda8b6b640b2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.22e-06 | 198 | 207 | 8 | 22935a8afac54021f68b5f7a5accf51523e2f336 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.54e-06 | 200 | 207 | 8 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.54e-06 | 200 | 207 | 8 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.54e-06 | 200 | 207 | 8 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.54e-06 | 200 | 207 | 8 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.54e-06 | 200 | 207 | 8 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.54e-06 | 200 | 207 | 8 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.54e-06 | 200 | 207 | 8 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.54e-06 | 200 | 207 | 8 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.54e-06 | 200 | 207 | 8 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 165 | 207 | 7 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-05 | 168 | 207 | 7 | fa7c0303918cea04e3f4c4f3cb079be19004d214 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-05 | 168 | 207 | 7 | 7edcab103c69e928d5c19a0d218ffb3ae32f9e70 | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.39e-05 | 168 | 207 | 7 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-05 | 169 | 207 | 7 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-05 | 169 | 207 | 7 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.68e-05 | 173 | 207 | 7 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | 11.5-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 1.68e-05 | 173 | 207 | 7 | 6989c9cebcd81eccceac7e5a86152676ee959386 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 1.68e-05 | 173 | 207 | 7 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-4|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.75e-05 | 174 | 207 | 7 | 15e2b9f46404ff9575e149024b24cb17b50b02b5 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.95e-05 | 177 | 207 | 7 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.10e-05 | 179 | 207 | 7 | b1f085e4c8d65d5cdbfaf2db80343638abb08979 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 180 | 207 | 7 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-05 | 180 | 207 | 7 | adf5db5bfa9a38b1227ab0beccd8d6f3eea67ac0 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-05 | 180 | 207 | 7 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-05 | 180 | 207 | 7 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 182 | 207 | 7 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-05 | 184 | 207 | 7 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.50e-05 | 184 | 207 | 7 | a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-club_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.50e-05 | 184 | 207 | 7 | ab469b9e06212462cbe2e4db8775c6778db855e6 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-05 | 184 | 207 | 7 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 185 | 207 | 7 | 53854a9ec87c24c360541c83d86d8fafb303ad58 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 185 | 207 | 7 | a61fc7a3700a1efcf640bef7680c0443ee148a46 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-05 | 186 | 207 | 7 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-05 | 187 | 207 | 7 | c667fae6440dc98072b584f203d00f0fb1cb2f21 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-05 | 188 | 207 | 7 | ecc2364d946f97ae0212fd6739960c9fc75e4919 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.97e-05 | 189 | 207 | 7 | 38cde34295566a4ecaf7d0a81c5a192cf17d0459 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.97e-05 | 189 | 207 | 7 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.97e-05 | 189 | 207 | 7 | a85099bd598a27ee64ee0664d051d89fa8d62fc9 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.07e-05 | 190 | 207 | 7 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.07e-05 | 190 | 207 | 7 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 191 | 207 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-05 | 191 | 207 | 7 | acd844b477a069b2dcf07b2998e1b5c87dc0eb94 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-05 | 191 | 207 | 7 | bda8faf92495c8b362850c0aff4fc6fbdd9c563b | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-05 | 191 | 207 | 7 | 6880fb348bb0915db9a5da4f3566ca9ff93ed258 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 3.18e-05 | 191 | 207 | 7 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-05 | 191 | 207 | 7 | e8d56e9f43943e9cc4dce83f2c234f19c2dd487d | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-05 | 191 | 207 | 7 | 52e8d7dfaf1ebb6df8bf3a1f4546af59faa67657 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-05 | 191 | 207 | 7 | 1e21de183a9c09cfb6aad3f9b948087fb6bad061 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-05 | 191 | 207 | 7 | b55500eb416f4f339031acad16b2737e5b891d8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 191 | 207 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 3.18e-05 | 191 | 207 | 7 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-05 | 191 | 207 | 7 | 96483adb97c81208aa513782550acd8a08b63866 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 191 | 207 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.28e-05 | 192 | 207 | 7 | ac9e5288ecd4b1e142f2e15a1fcd11c8eb9e15cd | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.28e-05 | 192 | 207 | 7 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-05 | 192 | 207 | 7 | b5cdc2dae3154b1e4ade88f841f38584402ffe33 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.28e-05 | 192 | 207 | 7 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-05 | 192 | 207 | 7 | 2d8d5a38e205339eda9c8aca1ca9ba3dcbe5ae56 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.39e-05 | 193 | 207 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.39e-05 | 193 | 207 | 7 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 3.51e-05 | 194 | 207 | 7 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 195 | 207 | 7 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 195 | 207 | 7 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 195 | 207 | 7 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.62e-05 | 195 | 207 | 7 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.62e-05 | 195 | 207 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.62e-05 | 195 | 207 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.74e-05 | 196 | 207 | 7 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.74e-05 | 196 | 207 | 7 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.74e-05 | 196 | 207 | 7 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.74e-05 | 196 | 207 | 7 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.74e-05 | 196 | 207 | 7 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.74e-05 | 196 | 207 | 7 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.74e-05 | 196 | 207 | 7 | faa39c567f24403e511b240c1d1a654ffadd8473 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.74e-05 | 196 | 207 | 7 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-05 | 197 | 207 | 7 | ea746772adb9df4ddb0508d4ef35f2027bf09c35 | |
| Drug | AC1N38XE | 1.31e-06 | 10 | 206 | 4 | CID004060965 | |
| Drug | rotenone; Up 200; 1uM; PC3; HT_HG-U133A | GALNT3 ATP9B BNC1 AP2S1 SCN9A ZER1 GNAS NOX1 PRKACG SENP6 SENP7 | 2.12e-06 | 199 | 206 | 11 | 5920_UP |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 8.71e-06 | 188 | 206 | 10 | 6926_UP | |
| Drug | 5-methylcytosine | GAD1 RB1CC1 BDNF KAT2B SERPINB3 SERPINB4 HPRT1 ECEL1 RB1 POLA1 NAA50 | 9.60e-06 | 233 | 206 | 11 | CID000065040 |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A | GAD1 TBC1D2 ATP9B RB1CC1 BMP7 HSPA12A GPC4 OTULINL CYFIP2 MTMR6 | 1.05e-05 | 192 | 206 | 10 | 5206_UP |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 10uM; PC3; HT_HG-U133A | 1.10e-05 | 193 | 206 | 10 | 7388_DN | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; HL60; HT_HG-U133A | CDK16 TXNL4A ERAP2 ARIH2 KIF2A FLII DNAH3 RNPEPL1 KCTD20 SENP6 | 1.25e-05 | 196 | 206 | 10 | 2388_DN |
| Drug | Glucose | GAD1 TMEM128 HK1 GALNT3 RB1CC1 HNF4A TLK1 KAT2B HSPA12A TXNL4A PXDN RAB3GAP2 MCM3AP C3 ALB KIF5B ATL2 TAF1D HSP90AB1 KPNA3 NAA15 SGK1 BTBD10 BCCIP CHD9 CHD7 DENND1A NOX1 FTH1 DOP1A | 1.28e-05 | 1420 | 206 | 30 | ctd:D005947 |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; MCF7; HT_HG-U133A | 1.31e-05 | 197 | 206 | 10 | 3338_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.31e-05 | 197 | 206 | 10 | 2667_UP | |
| Drug | AC1L1COZ | 1.77e-05 | 90 | 206 | 7 | CID000001996 | |
| Drug | NSC226080 | ATP8A2 PDPK1 RPS6KA2 RB1CC1 BDNF RYR3 MYO3A TLK1 HPRT1 CLTC HSP90AB1 MAP2K4 SLC25A21 RB1 SGK1 NAA50 ASH2L PPP3CA EIF3C QRSL1 | 3.06e-05 | 782 | 206 | 20 | CID000005040 |
| Drug | 15d-PGJ2; Up 200; 10uM; HL60; HT_HG-U133A | 3.37e-05 | 176 | 206 | 9 | 1172_UP | |
| Drug | 3'-deoxy-ara-C | 3.95e-05 | 8 | 206 | 3 | CID000122111 | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 4.01e-05 | 180 | 206 | 9 | 1076_DN | |
| Drug | panaxydol | 5.89e-05 | 9 | 206 | 3 | ctd:C055778 | |
| Drug | AC1N9ZZC | 6.56e-05 | 149 | 206 | 8 | CID004369374 | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 10uM; PC3; HT_HG-U133A | 6.62e-05 | 192 | 206 | 9 | 4288_DN | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 7.17e-05 | 194 | 206 | 9 | 6833_DN | |
| Drug | Ethamivan [304-84-7]; Down 200; 18uM; PC3; HT_HG-U133A | 7.17e-05 | 194 | 206 | 9 | 7260_DN | |
| Drug | CP-645525-01 [287190-82-3]; Up 200; 10uM; MCF7; HT_HG-U133A | 7.17e-05 | 194 | 206 | 9 | 7522_UP | |
| Drug | Tolazamide [1156-19-0]; Down 200; 12.8uM; PC3; HT_HG-U133A | 7.76e-05 | 196 | 206 | 9 | 4003_DN | |
| Drug | Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 7.76e-05 | 196 | 206 | 9 | 7222_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 8.07e-05 | 197 | 206 | 9 | 3848_DN | |
| Drug | Vinpocetine [42971-09-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 8.07e-05 | 197 | 206 | 9 | 7213_DN | |
| Drug | Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; MCF7; HT_HG-U133A | 8.07e-05 | 197 | 206 | 9 | 5250_UP | |
| Drug | Pheniramine maleate [132-20-7]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 8.07e-05 | 197 | 206 | 9 | 1492_DN | |
| Drug | Boldine [476-70-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 8.07e-05 | 197 | 206 | 9 | 2804_DN | |
| Drug | Condor | 8.36e-05 | 10 | 206 | 3 | CID000091699 | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; HL60; HG-U133A | 8.39e-05 | 198 | 206 | 9 | 1404_DN | |
| Drug | prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 8.39e-05 | 198 | 206 | 9 | 6552_UP | |
| Drug | Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 8.39e-05 | 198 | 206 | 9 | 1544_DN | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 8.39e-05 | 198 | 206 | 9 | 5325_DN | |
| Drug | Nafronyl oxalate [3200-06-4]; Down 200; 8.4uM; PC3; HT_HG-U133A | MYO9A ATP9B RB1CC1 TXNL4A RAB3GAP2 CYP7B1 OTULINL TMEM121 SENP6 | 8.39e-05 | 198 | 206 | 9 | 6687_DN |
| Drug | Dioxybenzone [131-53-3]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 8.39e-05 | 198 | 206 | 9 | 5699_DN | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 8.39e-05 | 198 | 206 | 9 | 3609_DN | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; PC3; HT_HG-U133A | 8.72e-05 | 199 | 206 | 9 | 3813_DN | |
| Drug | Bromopride [4093-35-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 8.72e-05 | 199 | 206 | 9 | 4741_DN | |
| Drug | semustine; Down 200; 100uM; MCF7; HT_HG-U133A | ATP8A2 RPS6KA2 TBC1D2 TIMELESS ATL2 CUL2 SLC25A21 NIPAL3 TMEM121 | 8.72e-05 | 199 | 206 | 9 | 7487_DN |
| Drug | Cyproterone acetate [427-51-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 8.72e-05 | 199 | 206 | 9 | 6806_DN | |
| Disease | factor VIII deficiency (is_marker_for) | 1.28e-06 | 4 | 203 | 3 | DOID:12134 (is_marker_for) | |
| Disease | age at menopause | BDNF BNC1 TLK1 USP3 KPNA3 IPO7 FERMT1 CHD7 DENND1A ASH2L PTGR1 | 8.68e-06 | 302 | 203 | 11 | EFO_0004704 |
| Disease | Malignant neoplasm of prostate | GALNT3 TBC1D2 BMP7 CPNE3 CYP7B1 HSP90AB1 RAG1 RB1 GPX3 CHD7 IDH1 NIPAL3 PPP3CA CHEK2 SENP6 | 2.64e-05 | 616 | 203 | 15 | C0376358 |
| Disease | Prostatic Neoplasms | GALNT3 TBC1D2 BMP7 CPNE3 CYP7B1 HSP90AB1 RAG1 RB1 GPX3 CHD7 IDH1 NIPAL3 PPP3CA CHEK2 SENP6 | 2.64e-05 | 616 | 203 | 15 | C0033578 |
| Disease | Diffuse Large B-Cell Lymphoma | 3.86e-05 | 55 | 203 | 5 | C0079744 | |
| Disease | erythema nodosum (is_marker_for) | 4.71e-05 | 2 | 203 | 2 | DOID:0080750 (is_marker_for) | |
| Disease | X-linked spondyloepiphyseal dysplasia tarda (implicated_via_orthology) | 4.71e-05 | 2 | 203 | 2 | DOID:0080362 (implicated_via_orthology) | |
| Disease | boutonneuse fever (is_marker_for) | 4.71e-05 | 2 | 203 | 2 | DOID:14095 (is_marker_for) | |
| Disease | anterior uveitis (is_marker_for) | 4.71e-05 | 2 | 203 | 2 | DOID:1407 (is_marker_for) | |
| Disease | conjunctivitis (is_marker_for) | 4.71e-05 | 2 | 203 | 2 | DOID:6195 (is_marker_for) | |
| Disease | Hemolytic-Uremic Syndrome | 5.08e-05 | 11 | 203 | 3 | C0019061 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.54e-05 | 195 | 203 | 8 | DOID:1574 (implicated_via_orthology) | |
| Disease | wet macular degeneration | 1.10e-04 | 14 | 203 | 3 | EFO_0004683 | |
| Disease | sickle cell anemia (is_marker_for) | 1.10e-04 | 14 | 203 | 3 | DOID:10923 (is_marker_for) | |
| Disease | complement C3D fragment measurement | 1.41e-04 | 3 | 203 | 2 | EFO_0020277 | |
| Disease | Bone osteosarcoma | 1.41e-04 | 3 | 203 | 2 | cv:C0585442 | |
| Disease | hereditary spastic paraplegia 3A (implicated_via_orthology) | 1.41e-04 | 3 | 203 | 2 | DOID:0110791 (implicated_via_orthology) | |
| Disease | OSTEOGENIC SARCOMA | 1.41e-04 | 3 | 203 | 2 | 259500 | |
| Disease | Schizophrenia | CDK16 GAD1 HK1 INPP5A CHAT RB1CC1 DCC BDNF HSPA12A PTPRZ1 KIF2A GNAS APOL2 KPNA3 PSD3 ARHGAP1 MYO16 | 1.41e-04 | 883 | 203 | 17 | C0036341 |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.80e-04 | 41 | 203 | 4 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.80e-04 | 41 | 203 | 4 | C0858252 | |
| Disease | lepromatous leprosy (is_marker_for) | 2.80e-04 | 4 | 203 | 2 | DOID:10887 (is_marker_for) | |
| Disease | Endogenous depression | 2.83e-04 | 46 | 203 | 4 | C0011573 | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 3.89e-04 | 21 | 203 | 3 | OBA_2045104 | |
| Disease | Immunologic Deficiency Syndromes | 5.13e-04 | 23 | 203 | 3 | C0021051 | |
| Disease | Ovarian Serous Adenocarcinoma | 5.13e-04 | 23 | 203 | 3 | C1335177 | |
| Disease | atrophic macular degeneration | 6.60e-04 | 25 | 203 | 3 | EFO_1001492 | |
| Disease | paroxysmal nocturnal hemoglobinuria (is_implicated_in) | 6.94e-04 | 6 | 203 | 2 | DOID:0060284 (is_implicated_in) | |
| Disease | Idiopathic Membranous Glomerulonephritis | 6.94e-04 | 6 | 203 | 2 | C0086445 | |
| Disease | Heymann Nephritis | 6.94e-04 | 6 | 203 | 2 | C1704378 | |
| Disease | Membranous glomerulonephritis | 6.94e-04 | 6 | 203 | 2 | C0017665 | |
| Disease | spondyloepiphyseal dysplasia congenita (implicated_via_orthology) | 6.94e-04 | 6 | 203 | 2 | DOID:14789 (implicated_via_orthology) | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 9.22e-04 | 108 | 203 | 5 | DOID:684 (biomarker_via_orthology) | |
| Disease | embryonal carcinoma (is_marker_for) | 9.67e-04 | 7 | 203 | 2 | DOID:3308 (is_marker_for) | |
| Disease | ER membrane protein complex subunit 4 measurement | 9.67e-04 | 7 | 203 | 2 | EFO_0801580 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 9.67e-04 | 7 | 203 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | pyelonephritis (is_marker_for) | 9.67e-04 | 7 | 203 | 2 | DOID:11400 (is_marker_for) | |
| Disease | smoking behaviour measurement, body mass index | 9.67e-04 | 7 | 203 | 2 | EFO_0004340, EFO_0005671 | |
| Disease | Glomerulonephritis, Membranoproliferative | 9.67e-04 | 7 | 203 | 2 | C0017662 | |
| Disease | Age related macular degeneration | 1.14e-03 | 30 | 203 | 3 | C0242383 | |
| Disease | guanosine monophosphate measurement | 1.28e-03 | 8 | 203 | 2 | EFO_0010495 | |
| Disease | atypical hemolytic-uremic syndrome (is_implicated_in) | 1.28e-03 | 8 | 203 | 2 | DOID:0080301 (is_implicated_in) | |
| Disease | phosphatidylethanolamine measurement | 1.30e-03 | 173 | 203 | 6 | EFO_0010228 | |
| Disease | Cleft palate | 1.47e-03 | 71 | 203 | 4 | HP_0000175 | |
| Disease | Complement deficiency disease | 1.50e-03 | 33 | 203 | 3 | C0272242 | |
| Disease | Atypical hemolytic-uremic syndrome | 1.64e-03 | 9 | 203 | 2 | cv:C2931788 | |
| Disease | level of Sterol ester (27:1/16:1) in blood serum | 1.64e-03 | 9 | 203 | 2 | OBA_2045190 | |
| Disease | tumor necrosis factor ligand superfamily member 14 measurement | 1.64e-03 | 9 | 203 | 2 | EFO_0010613 | |
| Disease | level of Phosphatidylcholine (16:0_20:5) in blood serum | 1.64e-03 | 9 | 203 | 2 | OBA_2045077 | |
| Disease | C3 glomerulopathy | 1.64e-03 | 9 | 203 | 2 | C4087273 | |
| Disease | Hemolytic-uremic syndrome | 1.64e-03 | 9 | 203 | 2 | cv:C0019061 | |
| Disease | electroencephalogram measurement | 1.72e-03 | 74 | 203 | 4 | EFO_0004357 | |
| Disease | serum gamma-glutamyl transferase measurement | GALNT3 MYO9A HNF4A KAT2B HPRT1 ZER1 C3 USP3 RNF135 PSD3 CHD9 COLEC10 CYFIP2 SLCO1B7 CHEK2 | 1.74e-03 | 914 | 203 | 15 | EFO_0004532 |
| Disease | intellectual disability (implicated_via_orthology) | 1.81e-03 | 75 | 203 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | alkaline phosphatase measurement | EMC1 GALNT3 HNF4A MYO3A TLK1 APOL2 PCYOX1 MAP2K4 MACC1 RAPSN ATP13A1 RBL2 PSD3 COLEC10 CHEK2 SENP7 | 1.85e-03 | 1015 | 203 | 16 | EFO_0004533 |
| Disease | Atypical Hemolytic Uremic Syndrome | 2.04e-03 | 10 | 203 | 2 | C2931788 | |
| Disease | Congenital myasthenic syndrome | 2.04e-03 | 10 | 203 | 2 | cv:C0751882 | |
| Disease | level of Sterol ester (27:1/18:3) in blood serum | 2.04e-03 | 10 | 203 | 2 | OBA_2045193 | |
| Disease | Unipolar Depression | 2.19e-03 | 259 | 203 | 7 | C0041696 | |
| Disease | Adrenal Gland Neoplasms | 2.49e-03 | 11 | 203 | 2 | C0001624 | |
| Disease | level of Sterol ester (27:1/20:5) in blood serum | 2.49e-03 | 11 | 203 | 2 | OBA_2045197 | |
| Disease | Adrenal Cancer | 2.49e-03 | 11 | 203 | 2 | C0750887 | |
| Disease | quality of life during menstruation measurement, acne | 2.49e-03 | 11 | 203 | 2 | EFO_0003894, EFO_0009366 | |
| Disease | 1-methylxanthine measurement | 2.49e-03 | 11 | 203 | 2 | EFO_0021174 | |
| Disease | Profound Mental Retardation | 2.80e-03 | 139 | 203 | 5 | C0020796 | |
| Disease | Mental deficiency | 2.80e-03 | 139 | 203 | 5 | C0917816 | |
| Disease | Cocaine Dependence | 2.80e-03 | 139 | 203 | 5 | C0600427 | |
| Disease | Mental Retardation, Psychosocial | 2.80e-03 | 139 | 203 | 5 | C0025363 | |
| Disease | kidney disease (implicated_via_orthology) | 2.82e-03 | 41 | 203 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | Depression, Neurotic | 2.82e-03 | 41 | 203 | 3 | C0282126 | |
| Disease | Melancholia | 2.82e-03 | 41 | 203 | 3 | C0025193 | |
| Disease | lysophosphatidylethanolamine measurement | 2.82e-03 | 41 | 203 | 3 | EFO_0010225 | |
| Disease | response to carboplatin, methylcobalamin deficiency type cblE, response to antineoplastic agent | 2.97e-03 | 12 | 203 | 2 | GO_0097327, GO_0097328, MONDO_0009354 | |
| Disease | Depressive Syndrome | 3.02e-03 | 42 | 203 | 3 | C0086133 | |
| Disease | Charcot-Marie-Tooth disease | 3.02e-03 | 42 | 203 | 3 | cv:C0007959 | |
| Disease | Kidney Diseases | 3.23e-03 | 88 | 203 | 4 | C0022658 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 3.23e-03 | 43 | 203 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | retinal vasculature measurement | 3.25e-03 | 517 | 203 | 10 | EFO_0010554 | |
| Disease | cholesteryl ester 20:4 measurement | 3.45e-03 | 44 | 203 | 3 | EFO_0010348 | |
| Disease | fatty acid measurement, fetal genotype effect measurement, breast milk measurement | 3.49e-03 | 13 | 203 | 2 | EFO_0005110, EFO_0007959, EFO_0009092 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 3.49e-03 | 13 | 203 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | rhinitis (biomarker_via_orthology) | 3.49e-03 | 13 | 203 | 2 | DOID:4483 (biomarker_via_orthology) | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 3.49e-03 | 13 | 203 | 2 | C0270914 | |
| Disease | esophageal cancer (is_implicated_in) | 3.49e-03 | 13 | 203 | 2 | DOID:5041 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | MCF2L2 DCC NLGN4X MCM3AP P2RY14 GNAS IQUB DNAH3 RNPEPL1 HAT1 IDH1 CHEK2 | 3.58e-03 | 702 | 203 | 12 | C0009402 |
| Disease | obesity (implicated_via_orthology) | 3.84e-03 | 215 | 203 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 3.94e-03 | 93 | 203 | 4 | DOID:3525 (biomarker_via_orthology) | |
| Disease | Intellectual Disability | 3.97e-03 | 447 | 203 | 9 | C3714756 | |
| Disease | Depressive disorder | 4.01e-03 | 289 | 203 | 7 | C0011581 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement | 4.06e-03 | 14 | 203 | 2 | EFO_0022085 | |
| Disease | Spastic Paraplegia, Hereditary | 4.06e-03 | 14 | 203 | 2 | C0037773 | |
| Disease | fatty acid measurement, breast milk measurement, parental genotype effect measurement | 4.06e-03 | 14 | 203 | 2 | EFO_0005110, EFO_0005939, EFO_0009092 | |
| Disease | insulin metabolic clearance rate measurement, glucose homeostasis measurement | 4.06e-03 | 14 | 203 | 2 | EFO_0006830, EFO_0006896 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.10e-03 | 152 | 203 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Down syndrome (implicated_via_orthology) | 4.66e-03 | 15 | 203 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | phosphatidylcholine 36:3 measurement | 4.66e-03 | 15 | 203 | 2 | EFO_0010381 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 4.92e-03 | 99 | 203 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | Vitiligo | 5.28e-03 | 101 | 203 | 4 | EFO_0004208 | |
| Disease | vision disorder | 5.30e-03 | 16 | 203 | 2 | MONDO_0021084 | |
| Disease | phosphatidylcholine 38:6 measurement | 5.30e-03 | 16 | 203 | 2 | EFO_0010388 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLYKLFLDSYFKEGN | 306 | Q14146 | |
| NYDEYAIFLTKKFSR | 126 | P02760 | |
| KLYRFFKYIENRDVA | 341 | Q9BSF8 | |
| SIFIEDYLKYFQDQV | 6 | Q9BQE5 | |
| FHDNEETFLKKYLYE | 151 | P02768 | |
| EREVSIKKYKYFSNF | 1371 | Q9BXX2 | |
| LLFLLEEYKNYLDAA | 106 | P23560 | |
| DREKYFKKFFNYINL | 211 | Q13939 | |
| YFELKAKYYVQLEQL | 211 | O60239 | |
| SFEFQKIKYSYDALE | 171 | Q9HD20 | |
| FKQYAGKYVLFVNVA | 56 | P22352 | |
| EQLLLRFKYYSFFDL | 266 | Q9BQL6 | |
| FRAAYLLKDVAKEAY | 791 | Q01954 | |
| KFYYIYNEKGLEVTI | 241 | P01024 | |
| KTFIIDYYFEVVQKL | 61 | O75131 | |
| EEKFYYIVQEEKNYR | 156 | Q9Y6Z7 | |
| NYVAAIDKALKNFEY | 16 | Q5JWR5 | |
| AQAREALKKYLFYFE | 356 | O95376 | |
| EYLEFLKQLKHLAYE | 321 | P16066 | |
| LKDYYIFNKYLEKVV | 146 | Q96M95 | |
| IKIKNFFDAEDYYIV | 286 | O96017 | |
| VLYFDDSSNVILKKY | 406 | P18075 | |
| VEIEEFYVKYKNFSY | 821 | Q9P2D1 | |
| KYYRAILEKNFTFLS | 1216 | Q9P2D1 | |
| DFLLEAAKLANYAKY | 251 | Q8N5B7 | |
| YSLDKYTKTVFIQEF | 241 | P36575 | |
| KSFYEKLYNRIFNDL | 951 | Q96BY7 | |
| DYAIAQFSYLEKLLL | 851 | Q9NTI2 | |
| LDLVFNFYKVYTVVD | 101 | P53680 | |
| LIKFKSYLYFEEKDF | 511 | Q9UBL3 | |
| DKFYKYVYSVLDDVI | 186 | P45985 | |
| LNLKAFDFYKVIESF | 521 | P06400 | |
| EFYKIFQLEIGEVYK | 806 | P15918 | |
| LNVNEVFKYLAEKYL | 156 | Q9ULC3 | |
| IEKFQEKAYVEFQDY | 521 | P13056 | |
| SFYAQVKDYEKALFF | 171 | Q13702 | |
| DTDTKQVYFYLFKLL | 191 | Q92830 | |
| FKTKVREYYFAEAQI | 236 | P05546 | |
| KVSYFEIYLDKIRDL | 131 | P33176 | |
| KDFLYSYFKDKVDVL | 426 | P09960 | |
| FKAINKAYEEYVLSV | 331 | Q08999 | |
| EFYDYDVALIKLKNK | 571 | P00751 | |
| LNVFLFVDAFLKYEK | 21 | Q9Y5S8 | |
| KLLFKFESIYSNYLQ | 166 | Q8TDY2 | |
| KTFLEYLEYEKDVLN | 711 | Q9H2M9 | |
| FFTFEQYKKLLGYVS | 91 | Q9BQT8 | |
| KITAYILFYTLDKNI | 976 | P43146 | |
| FSELAEDKENYKKFY | 416 | P08238 | |
| EDIYKLAFEIIDQYF | 471 | O00505 | |
| LFCLLLYFYKEKNAN | 186 | Q6P499 | |
| KFYEADCYIVLKTFL | 521 | Q13045 | |
| ADTKQVYFYLFKLLR | 181 | Q92831 | |
| LQLSKQAKYEDLYAF | 96 | Q9Y217 | |
| DLQLLFAFEYVGKKY | 171 | Q9NXD2 | |
| YYEREKAFQKQEGFL | 31 | Q9Y6X6 | |
| DYQLGLAIKKFYSFR | 451 | Q86W26 | |
| SELFKDLFVELKRYY | 136 | O75487 | |
| KLYRFFKYIENRDVA | 291 | Q7Z5Y7 | |
| YYFVKEFGLIDTKEL | 191 | Q96BX8 | |
| LLQEVFRFAYYKLLK | 81 | Q96BI3 | |
| YNEKLIDIFQKYSDV | 271 | Q92484 | |
| YEQFKFFLNLYFLVI | 151 | O43861 | |
| YFFEKYSKDLLVEGL | 326 | Q9Y3R5 | |
| KLVSVEAFALAAKYY | 101 | Q8N6Q8 | |
| VQGDYFETLLYKIFV | 246 | Q658Y4 | |
| VYFFKNDLKKYDVPL | 1776 | O60318 | |
| FYEKAILKFNYSVQE | 256 | Q9P287 | |
| LAEYLYAKIKNREEF | 486 | Q99259 | |
| IDDNEYAYLKAIIFF | 281 | P41235 | |
| CFLKRKEDLQIYFKY | 701 | Q86YR7 | |
| IFPVSYNDKFYKDVL | 26 | Q9GZZ1 | |
| AQILKLFLSYDYAVK | 416 | Q9UHG3 | |
| LEKKLFDYFNQEVFR | 281 | Q14642 | |
| KQIFKIFYALVQYTL | 201 | O95373 | |
| EDVFLKYLNFATLYL | 206 | P35913 | |
| YEDYIEFIKKLPFTQ | 2756 | Q6ZR08 | |
| AEDNLIHKFKYAFYL | 231 | Q9NX02 | |
| KKVKALEIFAYALQY | 161 | O43301 | |
| YALQYFKEQALKELS | 171 | O43301 | |
| VDYEFEKLLYKIFGE | 351 | O43301 | |
| VKLYFTFQDDEKLYF | 116 | Q6A1A2 | |
| LEREFFFSVYINKEK | 256 | P31270 | |
| FADIEQYQFLYKVIL | 2266 | P23471 | |
| YALTKFKKQFLYDEI | 701 | Q96F07 | |
| LLAYYFTELKDDQVK | 6 | P19367 | |
| DDLYKLVNFFLKYRA | 541 | Q96MC2 | |
| FYDKFILLLDFNSLY | 851 | P09884 | |
| YEFEVHEKTYFKNIL | 526 | O95672 | |
| LFAFEIYFRKEKFLL | 676 | Q9BXJ9 | |
| VYKLQAEDYKFDFPV | 136 | Q9NXE4 | |
| SDAILEYKLYEALKF | 231 | Q9NUU6 | |
| NYTADYDKALIFNKI | 106 | O94905 | |
| GYKFFADLLDYIKAL | 71 | P00492 | |
| EKIYVLQGEFFLFYE | 441 | Q8NFY9 | |
| NVEKFAIETELIYKY | 161 | Q9Y6X9 | |
| ELISFPLKEYFKQYE | 941 | Q9Y6X9 | |
| YELDFKAFVQKNLVY | 436 | Q9H0J9 | |
| YFVKFLDAYAEHKLQ | 251 | P04062 | |
| AIFLEDAVYLYKNTL | 66 | Q86UW1 | |
| QIAYVRDFKAKVQYF | 521 | Q96J02 | |
| KKLELQVYATFFEIY | 356 | O00139 | |
| LFLNILAFAALYYKK | 686 | Q8NFZ3 | |
| LYLVFEFLSQDLKKY | 76 | Q00526 | |
| IVKIKFNIIASLYDY | 371 | Q99613 | |
| YFDRDDVALKNFAKY | 41 | P02794 | |
| IIYAFLSENFRKAYK | 301 | P47211 | |
| TQYELFFKKADLTEY | 231 | Q8N6G5 | |
| QKKYYRAILEKNFSF | 1106 | Q3L8U1 | |
| GRFKDIFQEIYDKQY | 221 | O75874 | |
| IFQEIYDKQYKSQFE | 226 | O75874 | |
| YFLVFEKYNKDGATL | 201 | O14929 | |
| KLQFSFKDNSYLYLV | 106 | P22612 | |
| AYLQQKELDLIDYKF | 236 | Q96AV8 | |
| YLNVYKKYVDLLDNT | 606 | Q8TD57 | |
| NFFLLKENYENYFVK | 381 | Q9H0R6 | |
| LTLVFEYLDKDLKQY | 236 | Q00536 | |
| YLHDKLDEYVKQFSI | 231 | Q14435 | |
| FEITIKARYFYNKVV | 246 | P01031 | |
| ENVFVKYKATLLDIY | 1571 | P01031 | |
| LEREFFFNVYINKEK | 281 | P31277 | |
| DLVEYFKAYIKIYQG | 351 | Q8NHH9 | |
| VFKYIDDKDVFQKFY | 421 | Q13617 | |
| VKLQLAFTAYKYVDI | 71 | Q9HD87 | |
| EQSDKVYEVYKIYIF | 286 | Q7Z388 | |
| QYFLDKIDVIKQADY | 176 | P63092 | |
| LLEYFKAYIKIYQGE | 321 | Q6DD88 | |
| YLNKYILDKVEEGAF | 71 | Q9H4E7 | |
| LRQSKIDYFLEYFKG | 561 | Q6ZN28 | |
| FLKYKCLLQQLYYTE | 641 | Q8NA54 | |
| YKIFFRDLFLVKENE | 26 | Q502W7 | |
| FEVFYKLLNILADYT | 106 | Q8TEH3 | |
| AFDKKVLKFDAYFQE | 91 | Q5JVL4 | |
| QASLKLLDFYEKYFD | 301 | Q6P179 | |
| FLKFDDKFAYLVSNI | 216 | O75881 | |
| KQFDVLKDDYDYVLI | 951 | Q8N766 | |
| YKDKFVIICVNIFEY | 276 | Q9H069 | |
| YTDVLQKIKYAFSLL | 316 | Q8TE68 | |
| YDEKLQFYSKIAYEV | 1021 | Q8IVF4 | |
| LFLNILAFAALYYKK | 686 | Q8N0W4 | |
| LTEYFTFKQECKIKY | 156 | Q08209 | |
| EKLDLKVYGTFFEIY | 346 | Q8N4N8 | |
| YLQKLGFDVVFNYKT | 181 | Q14914 | |
| FQILKYLFQIDVYDF | 601 | Q96PC5 | |
| IKAANYDFYQLLEEK | 626 | Q8ND04 | |
| FLESLFYDVKLQYAV | 806 | Q9NQT8 | |
| YFDFVRLRNYFKKEE | 621 | Q68CQ4 | |
| KLAFYSVDNQEKLLY | 386 | Q8IUD6 | |
| RFDDFLRAYVEKYKF | 461 | Q9HAU8 | |
| IDFYLKYLILEKASD | 781 | Q9BQF6 | |
| LKLTDYRGKYLVFFF | 101 | Q13162 | |
| VVILIFFYLYKNKGS | 51 | Q0VAQ4 | |
| VARGFFNYIEKLKYE | 156 | Q9H5J8 | |
| FFVKLYFTFQDDEKL | 141 | O15530 | |
| NEYLIFQKIIKLEYD | 286 | O15530 | |
| FQTADKLYFVLDYIN | 166 | O00141 | |
| KFGQKIFYVNYLSEL | 181 | Q07960 | |
| LEYADKIFTYIFILE | 1226 | Q15858 | |
| FLEAVVRKFDAIYKY | 441 | Q5C9Z4 | |
| KSYVYFVIQVLDAFL | 486 | G3V0H7 | |
| FCIALEKFSKAIYKY | 151 | Q7Z745 | |
| FFGLISFDRYYKIVK | 111 | Q15391 | |
| KLFGEKTYLFLQEYL | 106 | P29508 | |
| KTYLFLQEYLDAIKK | 111 | P29508 | |
| YLVAFAYKNVKFVLK | 71 | Q9UNL2 | |
| FENIKYEDALKILQY | 166 | Q8IVF2 | |
| VFVNEAAYYEKKEAF | 281 | P45381 | |
| FYENKVYNVKIRFLE | 351 | Q7Z7G1 | |
| FKDIITKVANVELYY | 1391 | Q00610 | |
| VKNLDFIVYKFDNYG | 506 | P28329 | |
| FIVYKFDNYGKTFIK | 511 | P28329 | |
| DFYLIFNDVAKFLKQ | 146 | Q96MX0 | |
| VLVLFALQAYESYKK | 416 | Q96F05 | |
| LKYSIDQEFLKEYFP | 371 | Q9BYT8 | |
| FFRNYKEAEAKLLEF | 1561 | Q96JI7 | |
| YEHKFYEIVNVLLKD | 2416 | Q96JI7 | |
| EFEEAYILKEQKYSF | 56 | P01242 | |
| YLQAYKEAFASEKAF | 116 | Q9UNS1 | |
| YKAFDLYEQRYAAVK | 471 | Q9UKI8 | |
| IKLENYFEELLKNLY | 991 | O15164 | |
| VVTYYVDFFKTLKEN | 61 | Q5BJH2 | |
| YYKFKLTREVLSLFV | 261 | Q7Z7L7 | |
| LKYFFAVDTAYVAKK | 91 | O95070 | |
| TDKFAQFDEYQLAKY | 366 | Q99973 | |
| SKVFLLQEELAYYKS | 311 | Q5EBL4 | |
| EKTYLFLQKYLDYVE | 111 | Q9UIV8 | |
| VDYFCDEFKTKYKIN | 241 | O95757 | |
| YLFFLMYLINKDETE | 4821 | Q15413 | |
| KFDDDFHIYVYDLVK | 246 | Q9Y657 | |
| LEIKLYFIFQNYKAA | 86 | Q9BTD3 | |
| FNTTENLYKKYVFLD | 176 | Q6VEQ5 | |
| FNTTENLYKKYVFLD | 176 | A8K0Z3 | |
| YSTYIKEFDKNIALL | 966 | Q6ZV73 | |
| FEDLENLKYLYLYKN | 106 | Q92626 | |
| KKKYFDFEEILAFVN | 276 | Q5T6S3 | |
| FLNDVIIDFYLKYLV | 681 | Q9GZR1 | |
| KLFGEKTYQFLQEYL | 106 | P48594 | |
| YSLEYFQFVKKLLTC | 2006 | O00507 | |
| KNFFTDVYDLYIKFS | 96 | P0DI81 | |
| ATAQFLKVYDLVKAY | 111 | O43167 | |
| LKVYDLVKAYTDFQN | 116 | O43167 | |
| ETVVKAKAYILFYVE | 496 | Q9Y6I4 | |
| KRLDVYLQEFELLYF | 1111 | Q2M389 | |
| DTYYQLVLFLVKAVK | 1646 | O43149 | |
| EVYKKENLEIYHTLF | 536 | Q86VQ6 | |
| EINFLFYYESVKKQP | 1046 | Q9Y2L5 | |
| YSIAEKVKNFAVIYL | 46 | P83876 | |
| FYEIQLELYEVKFEI | 116 | Q1A5X7 | |
| FYKLLSTFDLIKYDF | 386 | Q9Y2P4 | |
| YFVALYRFKALEKDD | 251 | Q96MF2 | |
| KNFFTDVYDLYIKFS | 96 | P0DI82 | |
| LLKFYTLDFALEEYV | 636 | Q5TAX3 | |
| LFSKLVKYDELYAAL | 956 | Q5T4S7 | |
| LYRSLEQFKAIYKLE | 556 | Q6BDS2 | |
| NEFSKLVAEEYLKFF | 611 | Q9NYI0 | |
| LLFNTTENLYKKYVF | 156 | Q9NQA3 | |
| YVKYGDFKLLEFLDL | 156 | Q6P2D8 | |
| VFRYALAIFKYNEKE | 821 | Q9BYX2 | |
| VYKNLLFLKSYEDDV | 866 | Q15386 | |
| EDIYKLAYEIIDQFF | 471 | O00629 | |
| YAFQTEGKLYLILDF | 126 | Q15349 | |
| GKLLDLEDFYYKEFL | 1531 | Q8NEV4 | |
| RYKDLYALFEQILEK | 1921 | B2RTY4 |